148 related articles for article (PubMed ID: 14678238)
1. Analgesic duration and kinetics of liposomal bupivacaine after subcutaneous injection in mice.
Grant GJ; Piskoun B; Bansinath M
Clin Exp Pharmacol Physiol; 2003 Dec; 30(12):966-8. PubMed ID: 14678238
[TBL] [Abstract][Full Text] [Related]
2. A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia.
Grant GJ; Barenholz Y; Bolotin EM; Bansinath M; Turndorf H; Piskoun B; Davidson EM
Anesthesiology; 2004 Jul; 101(1):133-7. PubMed ID: 15220782
[TBL] [Abstract][Full Text] [Related]
3. DRV liposomal bupivacaine: preparation, characterization, and in vivo evaluation in mice.
Grant GJ; Barenholz Y; Piskoun B; Bansinath M; Turndorf H; Bolotin EM
Pharm Res; 2001 Mar; 18(3):336-43. PubMed ID: 11442274
[TBL] [Abstract][Full Text] [Related]
4. High-dose bupivacaine remotely loaded into multivesicular liposomes demonstrates slow drug release without systemic toxic plasma concentrations after subcutaneous administration in humans.
Davidson EM; Barenholz Y; Cohen R; Haroutiunian S; Kagan L; Ginosar Y
Anesth Analg; 2010 Apr; 110(4):1018-23. PubMed ID: 20357145
[TBL] [Abstract][Full Text] [Related]
5. Prolonged analgesia with liposomal bupivacaine in a mouse model.
Grant GJ; Vermeulen K; Langerman L; Zakowski M; Turndorf H
Reg Anesth; 1994; 19(4):264-9. PubMed ID: 7947427
[TBL] [Abstract][Full Text] [Related]
6. A model to evaluate the pharmacokinetic and pharmacodynamic variables of extended-release products using in vivo tissue microdialysis in humans: bupivacaine-loaded microcapsules.
Kopacz DJ; Bernards CM; Allen HW; Landau C; Nandy P; Wu D; Lacouture PG
Anesth Analg; 2003 Jul; 97(1):124-31, table of contents. PubMed ID: 12818954
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, dose-ranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release liposomal bupivacaine, to bupivacaine HCl for postsurgical analgesia in total knee arthroplasty.
Bramlett K; Onel E; Viscusi ER; Jones K
Knee; 2012 Oct; 19(5):530-6. PubMed ID: 22285545
[TBL] [Abstract][Full Text] [Related]
8. Chlorpheniramine produces cutaneous analgesia in rats.
Chiu CC; Liu KS; Chen YW; Hung CH; Wang JJ
Pharmacol Rep; 2020 Aug; 72(4):827-832. PubMed ID: 32048250
[TBL] [Abstract][Full Text] [Related]
9. A Randomized, Multicenter, Double-Blind Study of Local Infiltration Analgesia with Liposomal Bupivacaine for Postsurgical Pain Following Total Knee Arthroplasty: Rationale and Design of the Pillar Trial.
Dysart S; Snyder MA; Mont MA
Surg Technol Int; 2016 Nov; 30():261-267. PubMed ID: 27824434
[TBL] [Abstract][Full Text] [Related]
10. Liposomal bupivacaine: an innovative nonopioid local analgesic for the management of postsurgical pain.
Candiotti K
Pharmacotherapy; 2012 Sep; 32(9 Suppl):19S-26S. PubMed ID: 22956491
[TBL] [Abstract][Full Text] [Related]
11. Kinetic and dynamic studies of liposomal bupivacaine and bupivacaine solution after subcutaneous injection in rats.
Yu HY; Li SD; Sun P
J Pharm Pharmacol; 2002 Sep; 54(9):1221-7. PubMed ID: 12356276
[TBL] [Abstract][Full Text] [Related]
12. An in vivo method for the quantitative evaluation of local anesthetics.
Grant GJ; Piskoun B; Lin A; Bansinath M
J Pharmacol Toxicol Methods; 2000; 43(1):69-72. PubMed ID: 11091131
[TBL] [Abstract][Full Text] [Related]
13. Prolonged analgesia from Bupisome and Bupigel formulations: from design and fabrication to improved stability.
Cohen R; Kanaan H; Grant GJ; Barenholz Y
J Control Release; 2012 Jun; 160(2):346-52. PubMed ID: 22233969
[TBL] [Abstract][Full Text] [Related]
14. Liposomal bupivacaine efficacy for postoperative pain following posterior vaginal surgery: a randomized, double-blind, placebo-controlled trial.
Jones CL; Gruber DD; Fischer JR; Leonard K; Hernandez SL
Am J Obstet Gynecol; 2018 Nov; 219(5):500.e1-500.e8. PubMed ID: 30273586
[TBL] [Abstract][Full Text] [Related]
15. Evolving Role of Local Anesthetics in Managing Postsurgical Analgesia.
Golembiewski J; Dasta J
Clin Ther; 2015 Jun; 37(6):1354-71. PubMed ID: 25866297
[TBL] [Abstract][Full Text] [Related]
16. Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double-blind, placebo-controlled trial.
Gorfine SR; Onel E; Patou G; Krivokapic ZV
Dis Colon Rectum; 2011 Dec; 54(12):1552-9. PubMed ID: 22067185
[TBL] [Abstract][Full Text] [Related]
17. No Difference in Early Analgesia Between Liposomal Bupivacaine Injection and Intrathecal Morphine After TKA.
Barrington JW; Emerson RH; Lovald ST; Lombardi AV; Berend KR
Clin Orthop Relat Res; 2017 Jan; 475(1):94-105. PubMed ID: 27339124
[TBL] [Abstract][Full Text] [Related]
18. Local sustained delivery of bupivacaine HCl from a new castor oil-based nanoemulsion system.
Rachmawati H; Arvin YA; Asyarie S; Anggadiredja K; Tjandrawinata RR; Storm G
Drug Deliv Transl Res; 2018 Jun; 8(3):515-524. PubMed ID: 29516407
[TBL] [Abstract][Full Text] [Related]
19. Time to onset of analgesia following local infiltration of liposome bupivacaine in healthy volunteers: a randomized, single-blind, sequential cohort, crossover study.
Apseloff G; Onel E; Patou G
Int J Clin Pharmacol Ther; 2013 May; 51(5):367-73. PubMed ID: 23458225
[TBL] [Abstract][Full Text] [Related]
20. Liposomal Bupivacaine: A Comparative Study of More Than 1000 Total Joint Arthroplasty Cases.
Barrington JW; Olugbode O; Lovald S; Ong K; Watson H; Emerson RH
Orthop Clin North Am; 2015 Oct; 46(4):469-77. PubMed ID: 26410636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
